p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5632-5636

  Debes, Jose D ^a   Schmidt, Lucy J ^a   Huang, Haojie ^a   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P300; RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; GENE TARGETING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ACETYLTRANSFERASES; ANDROGENS; CELL CYCLE PROTEINS; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MAP KINASE SIGNALING SYSTEM; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037108955     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Grossmann, M., Huang, H., and Tindall, D. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. (Bethesda), 93: 1687-1697, 2001.
2. Fu, M., Wang, C., Reutens, A., Wang, J., Angeletti, R., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M., and Pestell, R. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem., 275: 20853-20860, 2000.
3. Vo, N., and Goodman, R. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem., 276: 13505-13508, 2001.
4. Chen, T., Wang, L., and Farrar, W. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res., 60: 2132-2135, 2000.
5. Hobisch, A. Eder, I. Putz, T. Horninger, W. Bartsch, G. Klocker, H. and Culig, Z. Interleukin-6 regulates prostate-specific Protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res., 58: 4640-4645, 1998.
6. Boyes, J., Byfield, P., Nakatani, Y., and Ogryzko, V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature (Lond.), 396: 594-598, 1998.
7. Liu, S., Rand, A., Kelm, R., and Getz, M. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts. Oncogene, 19: 3352-3362, 2000.
8. Zhu, W., Smith, A., and Young, C. A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells. Endocrinology, 140: 5451-5454, 1999.
9. Ueda, T., Bruchovsky, N. and Sadar, M. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J. Biol. Chem., 277, 7076-7085, 2002.
10. Chakravarti, D., LaMorte, V., Nelson, M., Nakajima, T., Schulman, I., Juguilon, H., Montminy, M., and Evans, R. Role of CBP/p300 in nuclear receptor signaling. Nature (Lond.), 383: 99-102, 1996.
11. Elbashir, S., Harborth, J., Lendeckel, W., Yalcin, A., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
12. Ait-Si-Ali, S., Ramirez, S., Barre, F., Dkhissi, F., Magnaghi-Jaulin, L., Girault, J., Robin, P., Knibiehler, M., Pritchard, L., Ducommun, B., Trouche, D., and Harel-Bellan, A. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein EIA. Nature (Lond.), 396: 184-186, 1998.
13. Espinosa, J., and Emerson, B. Transcriptional regulation by p53 through Intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell, 8: 57-59, 2001.
14. Lin, D., Whitney, M., Yao, Z., and Keller, E. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin. Cancer Res., 7: 1773-1781, 2001.
15. Smith, P., Hobisch, A., Lin, D., Culig, Z., and Keller, E. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev., 12: 33-40, 2001.
16. Sakaguchi, K., Herrera, J., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C., and Apella, E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12: 2831-2871, 1998.
17. Zhang, W., and Bieker, J. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl. Acad. Sci. USA, 95: 9855-9860, 1998.